Literature DB >> 15668389

Requirement of phospholipase D1 activity in H-RasV12-induced transformation.

F Gregory Buchanan1, Matt McReynolds, Anthony Couvillon, Yoonseok Kam, Vijaykumar R Holla, Raymond N Dubois, John H Exton.   

Abstract

The ability of the Ras oncogene to transform normal cells has been well established. One downstream effector of Ras is the lipid hydrolyzing enzyme phospholipase D. Recent evidence has emerged indicating a role for phospholipase D in cell proliferation, membrane trafficking, and migration. To study the potential importance of phospholipase D in the oncogenic ability of Ras, we used Rat-2 fibroblasts with reduced phospholipase D1 activity (Rat-2V25). Here, we show that H-Ras transformation of Rat-2 fibroblasts requires normal phospholipase D1 activity. WT Rat-2 fibroblasts transfected with the H-RasV12 oncogene grew colonies in soft agar and tumors in nude mice. However, Rat-2V25 cells when transfected with the H-RasV12 oncogene did not form colonies in soft agar or produce tumors when xenografted onto nude mice. Interestingly, in the presence of phosphatidic acid, the product of phospholipase D, growth in soft agar and tumor formation was restored. We also observed a dramatic increase in the expression of phospholipase D1 in colorectal tumors when compared with adjacent normal mucosa. Our studies identify phospholipase D1 as a critical downstream mediator of H-Ras-induced tumor formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668389      PMCID: PMC547811          DOI: 10.1073/pnas.0406698102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

2.  Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras.

Authors:  J de Rooij; J L Bos
Journal:  Oncogene       Date:  1997-02-06       Impact factor: 9.867

Review 3.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

4.  Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-alpha.

Authors:  S M Hammond; J M Jenco; S Nakashima; K Cadwallader; Q Gu; S Cook; Y Nozawa; G D Prestwich; M A Frohman; A J Morris
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

5.  Evidence that v-Src-induced phospholipase D activity is mediated by a G protein.

Authors:  H Jiang; K Alexandropoulos; J Song; D A Foster
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

6.  Biological assays for Ras transformation.

Authors:  G J Clark; A D Cox; S M Graham; C J Der
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

7.  Ras mediates the activation of phospholipase D by v-Src.

Authors:  H Jiang; Z Lu; J Q Luo; A Wolfman; D A Foster
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

8.  Involvement of Ral GTPase in v-Src-induced phospholipase D activation.

Authors:  H Jiang; J Q Luo; T Urano; P Frankel; Z Lu; D A Foster; L A Feig
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

9.  v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine.

Authors:  J G Song; L M Pfeffer; D A Foster
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

10.  Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation.

Authors:  T Urano; R Emkey; L A Feig
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

View more
  34 in total

1.  Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor.

Authors:  Robert R Lavieri; Sarah A Scott; Paige E Selvy; Kwangho Kim; Satyawan Jadhav; Ryan D Morrison; J Scott Daniels; H Alex Brown; Craig W Lindsley
Journal:  J Med Chem       Date:  2010-09-23       Impact factor: 7.446

Review 2.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

Review 3.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

4.  Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.

Authors:  Mayur Gadiya; Noriko Mori; Maria D Cao; Yelena Mironchik; Samata Kakkad; Ingrid S Gribbestad; Kristine Glunde; Balaji Krishnamachary; Zaver M Bhujwalla
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

5.  Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.

Authors:  Robert Lavieri; Sarah A Scott; Jana A Lewis; Paige E Selvy; Michelle D Armstrong; H Alex Brown; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-03-06       Impact factor: 2.823

6.  Human phospholipase D activity transiently regulates pyrimidine biosynthesis in malignant gliomas.

Authors:  Thomas P Mathews; Salisha Hill; Kristie L Rose; Pavlina T Ivanova; Craig W Lindsley; H Alex Brown
Journal:  ACS Chem Biol       Date:  2015-02-17       Impact factor: 5.100

7.  Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.

Authors:  Dong Woo Kang; Do Sik Min
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

Review 8.  Functional regulation of phospholipase D expression in cancer and inflammation.

Authors:  Dong Woo Kang; Kang-Yell Choi; Do Sik Min
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

Review 9.  Cellular and physiological roles for phospholipase D1 in cancer.

Authors:  Yi Zhang; Michael A Frohman
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

10.  Romidepsin inhibits Ras-dependent growth transformation of NIH 3T3 fibroblasts and RIE-1 epithelial cells independently of Ras signaling inhibition.

Authors:  Ariella B Hanker; Kevin D Healy; Jean Nichols; Channing J Der
Journal:  J Mol Signal       Date:  2009-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.